Kensico Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-786,800
Closed -$80.8M 43
2021
Q4
$80.8M Buy
786,800
+261,900
+50% +$25.1M 2.4% 13
2021
Q3
$45.9M Buy
524,900
+199,900
+62% +$18.1M 1.41% 15
2021
Q2
$29.1M Buy
+325,000
New +$27.5M 0.84% 20

Other funds holding SYNH

Kensico Capital Management's SYNH Position: Q1 2022 in Review

Kensico Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 786,800 shares — an estimated $80.8M sold.

Kensico Capital Management first reported a position in SYNH in Q2 2021 and held it in 3 quarters. The position peaked at $80.8M in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Kensico Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Kensico Capital Management sold 786,800 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $80.8M.
  • Kensico Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 3 quarters.
  • Kensico Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $80.8M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Kensico Capital Management's 13F filing for Q1 2022, filed 16 May 2022.